New treatments in scleroderma: the rheumatologic perspective.
Righi
A
A
Cerinic
M Matucci
MM
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D012595:Scleroderma, Systemic / Q000188:drug therapy* / Q000276:immunology
D018501:Antirheumatic Agents; D005343:Fibrinolytic Agents; D007166:Immunosuppressive Agents